HHV-8 and HIV in Kaposi's Sarcoma Patients in Tanzania
Author Information
Author(s): Mwakigonja Amos R, Pyakurel Pawan, Kokhaei Parviz, Pak Fatemeh, Lema Leonard K, Kaaya Ephata E, Biberfeld Peter
Primary Institution: Muhimbili University of Health and Allied Sciences (MUHAS)
Hypothesis
What is the association between HHV-8 seroprevalence and HIV status in patients with Kaposi's sarcoma and other conditions?
Conclusion
HHV-8 seroprevalence is high among patients at MNH, particularly in those with Kaposi's sarcoma and HIV, suggesting a need for routine screening.
Supporting Evidence
- 66.3% of the studied cohort were HIV positive.
- 89% of patients had anti-HHV-8 antibodies.
- HHV-8 seroprevalence was highest in KS cases at 93.3%.
Takeaway
This study found that many people with Kaposi's sarcoma in Tanzania also have a virus called HHV-8, especially if they are HIV positive.
Methodology
The study evaluated 184 biopsies and sera from patients with Kaposi's sarcoma, non-KS tumors, and non-neoplastic conditions using histopathology, immunohistology, and serology.
Potential Biases
Potential observer errors and sampling bias from hospital data.
Limitations
The study may have selection bias due to its hospital-based design and the evolving nature of HHV-8 screening methods.
Participant Demographics
The cohort included 120 patients with Kaposi's sarcoma, 24 with non-KS tumors, and 40 with non-malignant conditions, predominantly male.
Statistical Information
P-Value
0.0048
Confidence Interval
CI = 91.6–99.9%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website